Document Detail


Treatment strategies for central nervous system infections.
MedLine Citation:
PMID:  19445565     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Central nervous system (CNS) infections continue to be an important cause of mortality and morbidity. Current strategies for prevention and therapy of CNS infection are compromised by incomplete understanding of the microbial-host interactions that contribute to its pathogenesis and emergence of antimicrobial-resistant microorganisms. Our development of successful strategies in prevention and treatment of bacterial meningitis requires multifactorial concepts and approaches, which include advances in vaccinology, epidemiology of meningitis, emergence of antimicrobial-resistant pathogens, knowledge of pharmacokinetics and pharmacodynamics of antimicrobial agents, as well as the pathogenesis of meningitis. Prevention of bacterial meningitis targeting microbes has been effective, such as vaccination. The introduction of the protein conjugate vaccines against Haemophilus influenzae type b, Streptococcus pneumoniae and Neisseria meningitidis has changed the epidemiology of bacterial meningitis. Antimicrobial chemoprophylaxis is efficacious in prevention against H. influenzae type b and N. meningitidis meningitis. Suspected bacterial meningitis is a medical emergency and requires empiric antimicrobial therapy without delay, but recognition of pathogens with increasing resistance to antimicrobial agents is an important factor in selection of empiric antimicrobial regimen. A more complete understanding of the microbial-host interactions that are involved in the pathogenesis of CNS infections and associated neurologic sequelae is likely to help in developing new strategies for prevention and therapy of CNS infection.
Authors:
Kwang Sik Kim
Related Documents :
19578105 - The causes and clinical significance of fever in systemic lupus erythematosus: a retros...
2672525 - Trench fever in belfast, and the nature of the 'relapsing fevers' in the united kingdom...
18881485 - A study of the relationship between the fever caused by bacterial pyrogens and the feve...
24461765 - Incidence of congenital cytomegalovirus infection in ireland: implications for screenin...
383285 - Toxicity of intrapleural bacillus calmette-guérin treatment in animals.
24709465 - The role of the placenta in feto-neonatal infections.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Expert opinion on pharmacotherapy     Volume:  10     ISSN:  1744-7666     ISO Abbreviation:  Expert Opin Pharmacother     Publication Date:  2009 Jun 
Date Detail:
Created Date:  2009-05-25     Completed Date:  2009-08-13     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100897346     Medline TA:  Expert Opin Pharmacother     Country:  England    
Other Details:
Languages:  eng     Pagination:  1307-17     Citation Subset:  IM    
Affiliation:
Division of Pediatric Infectious Diseases, Johns Hopkins University School of Medicine, 200 North Wolfe Street, Room 3157, Baltimore, MD 21287, USA. kwangkim@jhmi.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anti-Infective Agents / pharmacokinetics,  pharmacology,  therapeutic use*
Central Nervous System Infections / drug therapy*,  microbiology
Humans
Chemical
Reg. No./Substance:
0/Anti-Infective Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Casopitant: a new warrior in the antiemetic crusade.
Next Document:  Validation of the radiosurgery-based arteriovenous malformation score in a large linear accelerator ...